These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36527368)

  • 1. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
    Hegen H; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):182-195. PubMed ID: 36527368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
    Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
    Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
    Hegen H; Walde J; Berek K; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):169-181. PubMed ID: 36453167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
    Hegen H; Berek K; Deisenhammer F
    Wien Med Wochenschr; 2022 Nov; 172(15-16):337-345. PubMed ID: 35133530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases.
    Michetti L; Maffina F; Ravasio R; Barcella V; Radaelli M; Chiudinelli L; Sessa M; Alessio MG
    J Neuroimmunol; 2023 Jun; 379():578091. PubMed ID: 37210840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
    Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
    Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
    Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
    Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
    Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
    J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Diagnosis of Intrathecal Synthesis of Immunoglobulins: A Review about the Contribution of OCBs and K-index.
    Morello M; Mastrogiovanni S; Falcione F; Rossi V; Bernardini S; Casciani S; Viola A; Reali M; Pieri M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
    J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study.
    Hegen H; Berek K; Cavalla P; Christiansen M; Emeršič A; Di Filippo M; Gaetani L; Hassler M; Leurs C; Milosavljevic D; van Pesch V; Petersen T; Presslauer S; Rosenstein I; Rot U; Schnabl C; Teunissen C; Vecchio D; Vercellino M; Deisenhammer F
    Front Immunol; 2023; 14():1327947. PubMed ID: 38169789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
    Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
    Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
    Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
    J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.
    Feki S; Damak M; Sakka S; Ben Ali Y; Mejdoub S; Bouattour N; Hachicha H; Mhiri C; Masmoudi H
    Sci Rep; 2022 Sep; 12(1):16425. PubMed ID: 36180495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.